Antigen Presentation Recent Developments

International Archives of Allergy and Immunology

Volumn 110, Issue 4, 1996, Pages 299-307

  Rammensee, Hans Georg ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Antigen processing; Class I; Class II; Human leukocyte antigen; Major histocompatibility complex; Peptides

Indexed keywords

CELL ADHESION MOLECULE; CHAPERONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; PROTEASOME; PROTEIN;

ALLELE; ANTIGEN PRESENTATION; AUTOIMMUNITY; CELL KILLING; GENE LOCUS; GENETIC ORGANIZATION; HUMAN; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REVIEW;

EID: 0029948849     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237320     Document Type: Article

References (63)

1. Trowsdale J: Both man and bird and beast’: Comparative organization of MI 1C genes, lm-nuinogenctics 1995:41:1-17.
2. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich LLA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1995, Hum Immunol 1995:43: 149-164.
3. Stern L.J, Wiley DC: Antigenic peptide binding by class I and class II histocompatibility proteins, Structure 1994;2:245-251.
4. Bouvier M, Wiley DC: Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules, Science 1994:265: 398-402.
5. Rammcnsce H-G, Friedc T, Stevanovic S: M HC‘ligands and peptide motifs, First listing, Immu-nogcnetics 1995:41:178-228.
6. Barouch D, Friedc T, Stevanovic S, Tussey L, Smith K, Rowland-Jones S, Brand V, McMi-chael A, Rammcnsee H-G: HLA-A2 subtypes are functionally distinct in peptide binding and presentation, J Exp Med 1995:182:1847-1856.
7. Boon T, Gajewski TF, Coulic PG: From defined human tumor antigens to effective immunization, Immunol Today 1995:16:334-336.
8. Young JW, lnaba K: Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity, J Exp Med 1996;183:7-11.
9. Denhaan JMM, Sherman NE, Blokland E, Huezko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH, Goul-my E: Identification of a graft versus host disease-associated human minor histocompatibility antigen, Science 1995;268:1476-1480.
10. Wang W, Meadows LR, Denhaan JMM, Sherman NE, Chen Y, Blokland E, Shabanowitz J, Agulnik AL, Ilendrickson RC, Bishop CE, Hunt DF, Goulmy E, Engelhard VH: Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein, Science 1995; 269:1588-1590.
11. Scott DM, Ehrmann IF., Ellis PS, Bishop CE, Agulnik AL, Simpson E, Mitchell MJ: Identification of a mouse male specific transplantation antigen, H-Y, Nature 1995:376:695-698.
12. Lchner PJ, Cresswell P: Processing and delivery of peptides presented by MHC class I molecules, Cun' Opin Immunol 1996:8:59-67.
13. Lowe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R: Crystal structure of the 20S protca-some from the archaeon T, acidophilum at 3.4 A resolution, Science 1995;268:533-539.
14. Seemuller E, Iupas A, Stock D, Lowe J, Huber R, Baumesiter W: Proteasomc from Thermo-plasma acidophilum: A threonine proteasc, Science 1995:268:579- 582.
15. Niedennann G, Butz S, Ihlenfeldt HG, Grimm R, Lucchiari M, Hoschutzky H, Jung G, Maier B, Eichmann K: Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules, Immunity 1995:2: 289-299.
16. Eggcrs M, Boes-Fabian B, Ruppcrt T, Kloctzcl PM, Koszinowski UH: The cleavage preference of the proteasomc governs the yield of antigenic peptides, J Exp Med 1995; 182:1865-1870.
17. Dick LR, Aldrich C, Jameson SC, Moomaw CR, Pramanik BC, Doyle CK, Dcmartino GN, Bevan MJ, Forman JM, Slaughter CA: Proteolytic processing of ovalbumin and beta-galacto-sidase by the proteasomc to yield antigenic peptides, J Immunol 1994;152:3884-3894.
18. Fehling HJ, Swat W, Laplace C, Kuhn R, Rajew-sky K, Muller U, von Bochmer H: MHC class I expression in mice lacking the proteasome subunit LMP-7, Science 1994:265:1234-1237.
19. Van Kaer L, Ashton Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S: Altered peptidase and viral-specific T ccll response in LMP2 mutant mice, Immunity 1994: 1:533-541.
20. Gaczynska M, Rock KL, Goldberg AL: Gam-ma-interferon and expression of MHC genes regulate peptide hydrolysis by protcasomes, Nature 1993;365:264-267.
21. Ustrell V, Pratt G, Rechsteiner M: Effects of in-terfcron-gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases, Proc Natl Acad Sci USA 1995;92:584-588.
22. Groettrup M, Ruppcrt T, Kuchn L, Seegcr M, Standcra S, Koszinowski U, Kloctzcl PM: The intcrferon-gamma-induciblc IIS regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20S proteasomc in vitro, J Biol Chem 1995:270:23808-23815.
23. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L., Hwang D, Goldberg Al: Inhibitors of the proteasomc block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules, Cell 1994;78:761-771.
24. Srivastava PK, Udono H, Blachcre NE, Li ZH: Heat-shock proteins transfer peptides during antigen-processing and CTL priming, Immuno-genetics 1994;39:93-98.
25. Powis SJ, Townsend ARM, Deverson EV, Bas-tin J, Butcher GW, Howard JC: Restoration of antigen presentation to the mutant-cell line RMA-S by an MHC-linked transporter, Nature 1991;354:528-531.
26. Momburg F, Ncctjcs JJ, Hammcrling GJ: Peptide selection by MHC-encoded TAP transporters, Curr Opin Immunol 1994;6:32-37.
27. Neeljes J, Gottfried E, Roelsc J, Gromme M, Obst R, Hammcrling GJ, Momburg F: Analysis of the fine specificity of rat, mouse and human TAP peptide transporters, Eur J Immunol 1995: 25:1133-1136.
28. Van Endert PM, Riganelli D, Greco G, Fleisch-hauer K, Sidney J, Sette A, Bach JF: The pep-tide-binding motif for the human transporter associated with antigen processing, J Exp Med 1995:182:1883-1895.
29. Obst R, Armandola EA, Nijenhuis M, Momburg F, Hammerling GJ: TAP polymorphism docs not influence transport of peptide variants in mice and humans, Eur J Immunol 1995;25: 2170-2176.
30. Falk K, Rotzschke O, Rammensee H-G: Cellular peptide composition governed by major histocompatibility complex class I molecules, Nature 1990;348:248-251.
31. Ortmann B, Androlewicz MJ, Cresswell P: MHC class I beta(2)-microglobulin complexes associate with TAP transporters before peptide binding, Nature 1994;368:864-867.
32. Suh WK, Cohen-Doyle MF, Fruh K, Wang K, Peterson PA, Williams DB: Interaction of MHC class I molecules with the transporter associated with antigen processing, Science 1994:264: 1322-1326.
33. Arnold D, Faath S, Rammensee LL-G, Schild H: Cross-priming of minor histocompatibility antigen-specific cytotoxic Tcells upon immunization with the heat-shock protein gp96, J Exp Med 1995:182:885-889.
34. Lammcrt E, Arnold D, Rammensee H-G, Schild H.: Expression levels of stress protein gp96 are not limiting for MI 1C class I-restricted antigen presentation, Eur J Immunol 1996:26: 875-879.
35. Bevan MJ: Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay, J Exp Med 1976:143:1283-1288.
36. Bevan MJ: Antigen presentation to cytotoxic T lymphocytes in vivo, J Exp Med 1995:182: 639-641.
37. Stem IJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Stromingcr JL, Wiley DC: Crystal strucuture of the human class II MHC protein HLA-DRI complexed with an influenza virus peptide, Nature 1994:368:215-221.
38. Ghosh P, Amaya M, Mellins E, Wiley DC: The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3, Nature 1995:378:457-462.
39. Hammer J, Bono E, Gallazzi F, Bclunis C, Nagy Z, Sinigaglia F: Precise prediction of major histocompatibility complex class II peptide interaction based on peptide side chain scanning, J Exp Med 1994:180:2353-2358.
40. Rammensee H-G: Chemistry of peptides associated with MHC class I and class II molecules, Curr Opin Immunol 1995;7:85-96.
41. Friede T, Gnau V, Jung G, Keilholz W, Steva-novic S, Rammensee H-G: Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides, Biochim Biophys Acta 1996;in press.
42. Hammer J, Gallazi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F: Peptide binding specificity of IILA-DR4 molecules: Correlation with rheumatoid arthritis association, J Exp Med 1995:181:1847-1855.
43. Busch R, Mellins ED: Developing and shedding inhibitions: How MHC class II molecules reach maturity, Curr Opin Immunol 1996:8:51 — 58.
44. Denzin LK, Cresswell P: IILA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading, Cell 1995:82:155-165.
45. Fling SP, Arp B, Pious D: HLA-DMA and 1ILA-DMB genes arc both required for MHC class-II peptide complex formation in antigen-presenting cells, Nature 1994:368:554-558.
46. Kelly AP, Monaco JJ, Cho SG, Trowsdalc J: A new human HLA class-11-rclated locus, DM, Nature 1991;353:571-573.
47. Bouwer HGA, Lindahl KF, Baldridge JR, Wagner CR, Barry RA, Hinrichs DJ: An II2-T MHC class lb molecule presents Listeria mono-cyfogenes-derived antigen to immune CD8(+) cytotoxic T cells, J Immunol 1994; 152:5352— 5360.
48. Aldrich CJ, DcCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J: Identification of a TAP-dependent leader peptide recognized by allo-reactivc T cells specific for a class lb antigen, Cell 1994;79:649-658.
49. Rotzschke O, Falk K, Stevanovic S, Grahovac B, Soloski MJ, Jung G, Rammensee H-G: Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules, Nature 1993;361:642-644.
50. Wang CR, Castano AR, Peterson PA, Slaughter C, Lindahl KF, Deisenhofcr J: Nonclassical binding of formylated peptide in crystal structure of the Ml 1C class lb molecule H2-M3, Cell 1995:82:655-664.
51. Lee N, Malacko AR, Ishitani A, Chen MC, Baj-orath J, Marquardt H, Geraghty DE: The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association, Immunity1995;3:591-600.
52. Diehl M, Miinz C, Kcilholz W, Stevanovic S, Ilolnics N, Loke YW, Rammensee H-G: Non-classical HLA-G molecules are classical peptide presenters, Curr Biol 1996;6:305-314.
53. Melian A, Beckman EM, Brenner MB: Antigen presentation by CD I and MHC-encodcd classl-like molecules, Curr Opin Immunol 1996:8: 82-88.
54. Siding PA, Chatterjee D, Porcelli SA, Prigozy TL, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kroncnberg M, Brennan PJ, Mo-dlin RL: CD I-restricted T cell recognition of microbial lipoglycan antigens, Science 1995: 269:227- 230.
55. C'astano AR, Tangri S, Miller JEW, Holcombc HR, Jackson MR, Husc WD, Kronenberg M Peterson PA: Peptide binding and presentation by mouse GDI, Science 1995;269:223-226.
56. Karre K: Express yourself or die: Peptides, MHC molecules, and NK cells, Science 1995: 267:978-979.
57. Yokoyama WM: Natural killer cell receptor* specific for major histocompatibility complex class I molecules, Proc Natl Acad Sci USA 1995;92:3081-3085.
58. Yokoyama WM: Natural killer cell receptors Curr Opin Immunol 1995;7:110:120.
59. Colonna M: NK cell receptors specific fot MHC class 1 molecules, Curr Opin Immunol 1996;8:101-107.
60. C'astelli C, Storkus WJ, Maeurer MJ, Martin DM, Huang EC, Pramanik BN, Nagabhushan TL, Parmiani G, Lotze MT: Mass spectrometric identification of a naturally processed melanoma peptide recognized bv CD8(+) cytotoxic T lymphocytes, J Exp Med 1995:181:363-368.
61. Panina-Bordignon P, Lang R, Van Endcrt PM, Bcnazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F: Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes, J Exp Med 1995; 181:1923-1927.
62. Brichard VG, Herman J, Van Pci A, Wildmann C, Gaugler B, Wolfcl T, Boon T, Lethe B: A tyrosinase nonapeptidc presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes, Eur J Immunol 1996;26:224-230.
63. Schild H, Griineberg U, Pougialis G, Wallny II-J, Keilholz W, Stevanovic S, Rammensee H-G: Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules, Int Immunol 1995;7: 1957-1965.